JP5048838B2 - ヒト敗血症を測定する方法 - Google Patents

ヒト敗血症を測定する方法 Download PDF

Info

Publication number
JP5048838B2
JP5048838B2 JP2010523316A JP2010523316A JP5048838B2 JP 5048838 B2 JP5048838 B2 JP 5048838B2 JP 2010523316 A JP2010523316 A JP 2010523316A JP 2010523316 A JP2010523316 A JP 2010523316A JP 5048838 B2 JP5048838 B2 JP 5048838B2
Authority
JP
Japan
Prior art keywords
psp
reg
sepsis
concentration
trauma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010523316A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010538282A5 (enExample
JP2010538282A (ja
Inventor
グラーフ、ロルフ
ビムラー、ダニエル
キール、マリウス
Original Assignee
ウニヴェルズィテート・ツューリヒ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40040164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5048838(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ウニヴェルズィテート・ツューリヒ filed Critical ウニヴェルズィテート・ツューリヒ
Publication of JP2010538282A publication Critical patent/JP2010538282A/ja
Publication of JP2010538282A5 publication Critical patent/JP2010538282A5/ja
Application granted granted Critical
Publication of JP5048838B2 publication Critical patent/JP5048838B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/474—Pancreatic thread protein; Reg protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
JP2010523316A 2007-09-07 2008-09-02 ヒト敗血症を測定する方法 Active JP5048838B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07017539.3 2007-09-07
EP07017539 2007-09-07
PCT/EP2008/007158 WO2009030456A1 (en) 2007-09-07 2008-09-02 Method for assaying sepsis in humans

Publications (3)

Publication Number Publication Date
JP2010538282A JP2010538282A (ja) 2010-12-09
JP2010538282A5 JP2010538282A5 (enExample) 2011-10-20
JP5048838B2 true JP5048838B2 (ja) 2012-10-17

Family

ID=40040164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010523316A Active JP5048838B2 (ja) 2007-09-07 2008-09-02 ヒト敗血症を測定する方法

Country Status (13)

Country Link
US (2) US8435755B2 (enExample)
EP (1) EP2185937B2 (enExample)
JP (1) JP5048838B2 (enExample)
CN (1) CN101796418B (enExample)
AT (1) ATE514950T1 (enExample)
AU (1) AU2008295046B2 (enExample)
CA (1) CA2696319C (enExample)
DK (1) DK2185937T4 (enExample)
ES (1) ES2368877T5 (enExample)
NZ (1) NZ583474A (enExample)
PL (1) PL2185937T5 (enExample)
PT (1) PT2185937E (enExample)
WO (1) WO2009030456A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2577316T3 (en) * 2010-05-31 2017-05-08 Univ Hospital Of Basel Procedure for testing for lower respiratory tract infections or inflammation
WO2012028594A1 (en) 2010-08-31 2012-03-08 Otto-Von-Guericke-Universität Magdeburg Method for assaying peritonitis in humans
US20130004968A1 (en) * 2010-09-22 2013-01-03 Robert Webber Sepsis blood biomarker system
WO2014009480A1 (en) 2012-07-12 2014-01-16 Universität Zürich Method for assaying sepsis and outcome in humans by detection of psp/reg
WO2014068018A1 (en) * 2012-10-30 2014-05-08 Abbott Gmbh & Co.Kg Methods of prognosis and diagnosis of sepsis
WO2014117165A1 (en) * 2013-01-28 2014-07-31 Vanderbilt University Method for differentiating sepsis and systemic inflammatory response syndrome (sirs)
EP2813852A3 (en) 2013-06-11 2015-03-25 University Of Zurich Method for detecting the development of an infection in humans
CN106367488A (zh) * 2016-08-29 2017-02-01 北京泱深生物信息技术有限公司 Letmd1在脓毒症诊断中的应用
EP3438668A1 (en) 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections
WO2019053118A1 (en) 2017-09-13 2019-03-21 B.R.A.H.M.S Gmbh PROADRÉNOMÉDULLINE AS A MARKER OF ABNORMAL PLATELET RATES
EP3502706A1 (en) 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
CN108181472B (zh) * 2018-03-05 2020-07-21 吉林大学 昆虫细胞表达psp为校准品的检测psp试剂盒
EP3578989A1 (en) * 2018-06-06 2019-12-11 B.R.A.H.M.S GmbH Pro-adm for prognosis of trauma-related complications in polytrauma patients
FR3087338B1 (fr) 2018-10-22 2020-10-09 Amadeite Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
CA3196464A1 (en) * 2020-11-03 2022-05-12 Nicolas Durand Method for assessing the severity of sars
US20250020663A1 (en) * 2021-11-25 2025-01-16 Abionic Sa Method for the management of antibiotic administration

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0378924B1 (en) 1988-12-21 1996-11-13 The General Hospital Corporation Detection of neurological disease or dysfunction
GB9613629D0 (en) * 1996-06-28 1996-08-28 Univ Leeds Reg gene expression in cancer tissue
DE50105971D1 (de) * 2001-12-04 2005-05-25 Brahms Ag Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125
EP1318405B1 (de) 2001-12-04 2004-11-17 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
DE50103032D1 (de) 2001-12-04 2004-09-02 Brahms Ag Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 19-9
DE50103030D1 (de) 2001-12-04 2004-09-02 Brahms Ag Verfahren zur Diagnose von Sepsis unter Bestimmung von S100B
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
JP2004194534A (ja) * 2002-12-17 2004-07-15 Sumitomo Pharmaceut Co Ltd 炎症性腸疾患疾患マーカーおよびその利用
EP1581812B1 (en) * 2003-01-06 2008-07-16 Wyeth Compositions and methods for diagnosing and treating colon cancers
WO2004087874A2 (en) * 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides
US20070224638A1 (en) 2006-03-27 2007-09-27 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
DK2577316T3 (en) * 2010-05-31 2017-05-08 Univ Hospital Of Basel Procedure for testing for lower respiratory tract infections or inflammation

Also Published As

Publication number Publication date
CN101796418A (zh) 2010-08-04
CA2696319A1 (en) 2009-03-12
PL2185937T5 (pl) 2014-12-31
AU2008295046B2 (en) 2013-08-01
CA2696319C (en) 2021-02-02
PL2185937T3 (pl) 2012-02-29
PT2185937E (pt) 2011-09-06
US20100222223A1 (en) 2010-09-02
DK2185937T4 (da) 2014-10-20
US9857381B2 (en) 2018-01-02
DK2185937T3 (da) 2011-09-12
ATE514950T1 (de) 2011-07-15
AU2008295046A1 (en) 2009-03-12
EP2185937B1 (en) 2011-06-29
CN101796418B (zh) 2013-05-01
JP2010538282A (ja) 2010-12-09
US20130203612A1 (en) 2013-08-08
ES2368877T3 (es) 2011-11-23
US8435755B2 (en) 2013-05-07
EP2185937B2 (en) 2014-07-16
ES2368877T5 (es) 2014-10-20
NZ583474A (en) 2011-07-29
WO2009030456A1 (en) 2009-03-12
EP2185937A1 (en) 2010-05-19

Similar Documents

Publication Publication Date Title
JP5048838B2 (ja) ヒト敗血症を測定する方法
Determann et al. Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study
JP5011410B2 (ja) 生体液のプロテオーム分析
EP1709444B1 (en) Method of diagnosing infectious disease by measuring the level of soluble trem-1 in a sample
US11041864B2 (en) Method for prediction of prognosis of sepsis
US20150045245A1 (en) Biomarkers and test panels useful in systemic inflammatory conditions
JP2006524331A5 (enExample)
US20160305957A1 (en) Il-6 detection based early diagnosis and prediction of systemic inflammatory response syndrome and sepsis in asymptomatic patients
KR20110104930A (ko) 갈렉틴-３ 면역검정
EP2612152B1 (en) Method to diagnose infectious peritonitis and predict the severity and outcome thereof in humans.
HK1215731A1 (zh) 借助抗利尿激素原对呼吸道和肺部的感染及慢性病的诊断和风险性分级
US20150118699A1 (en) Method for detecting disseminated intravascular coagulation or infectious disseminated intravascular coagulation
KR102164490B1 (ko) 알츠하이머성 치매 진단용 바이오마커 조성물 및 이의 용도
CN103207277B (zh) 一种人源性可溶型cd74蛋白的elisa检测试剂盒及检测方法
DK2577316T3 (en) Procedure for testing for lower respiratory tract infections or inflammation
Palmiere et al. Pancreatic stone protein as a postmortem biochemical marker for the diagnosis of sepsis
EP3087395B1 (en) Method for detecting a systemic inflammation and test system
CN116298327A (zh) 用于诊断脓毒症的标志物及其用途
CN117529664A (zh) 用于预测脓毒症和脓毒性休克的方法
EP2813852A2 (en) Method for detecting the development of an infection in humans
CN120275642B (zh) 组蛋白修饰标志物在脓毒症诊断产品制备中的应用及其试剂盒
Shi et al. Relationships between serum procalcitonin level, severity and different stresses of non-septic critically ill patients
CN119301455A (zh) 用于减少新生儿抗生素治疗的ptx3生物标志物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110831

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110831

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20120209

TRDD Decision of grant or rejection written
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120627

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120703

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120719

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150727

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5048838

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250